Dr. Kamal Masri, MD (he/him) is a Internist in Shreveport, LA with over 13 years of experience. What is your opinion of Dr. Kamal Masri, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 13 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Kamal Masri, MD has received over $3,783 which includes payments from the following companies:
$1,309.82 from Becton, Dickinson and Company
$345.98 from GlaxoSmithKline, LLC.
$266.25 from Allergan Inc.
$218.07 from Genentech USA, Inc.
$178.35 from Actelion Pharmaceuticals US, Inc.
$176.17 from Boehringer Ingelheim Pharmaceuticals, Inc.
$160.23 from Otsuka America Pharmaceutical, Inc.
$147.85 from Paratek Pharmaceuticals, Inc.
$125.00 from TETRAPHASE PHARMACEUTICALS, INC.
$125.00 from Melinta Therapeutics, Inc.
$113.86 from AbbVie, Inc.
$106.41 from Gilead Sciences Inc
$106.01 from E.R. Squibb & Sons, L.L.C.
$73.48 from Merck Sharp & Dohme Corporation
$57.47 from Valeant Pharmaceuticals North America LLC
$56.38 from Bayer HealthCare Pharmaceuticals Inc.
$43.41 from Pfizer Inc.
$39.16 from Salix Pharmaceuticals, Ltd
$31.20 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$28.76 from Janssen Pharmaceuticals, Inc
Payments received by Dr. Kamal Masri, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!